Investors are Betting Against Sarepta Therapeutics Inc. (SRPT) Should You? - Tale of the Tape
Many investors appear to be quite bearish
Sarepta Therapeutics Inc. (
especially if you look at the percentage of the float that is
sold short for this stock. Currently,
of the float is sold short, suggesting an extreme level of
However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2 (Buy) on SRPT, so we clearly don't believe in the negativity surrounding this firm, and are instead looking for shares of SRPT to move higher in the weeks ahead.
SAREPTA THERAP (SRPT): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research